ibrutinib,zanubrutinib
abbvie,beigene,janssen
['leukemia', 'zanubrutinib', 'cll', 'lba-6', ' ibru']
#ash22 press release: next-generation targeted therapy zanubrutinib found superior to ibrutinib for cll and sll. read more: 
The American Society of Hematology (ASH) is the world's largest professional society concerned with the causes and treatments of blood disorders.